The Thermogenesis Corporation has received an order for the BioArchive System from the Central Blood Bank of the Magen David Adom (MDA) in Ramat Gan, Israel. According to the Bi-Weekly Economic Update, the Company estimates that more than 70% of the cord blood stem cell transplants performed to date are from Cord Blood Banks that are now using the Company's BioArchive Systems. PCB stem cells are used to reconstitute the hematopoietic and immune systems of patients who have undergone high-dose chemotherapy and radiation to combat diseases such as leukemias, lymphomas, diverse inherited anemias, such as sickle cell anemia and thalassemia, and other genetic diseases.
This will be the first BioArchive System to be installed in Israel. Placement of the BioArchive System at this premier stem cell bank in Israel moves the Company one country closer to its goal of establishing a global network of national cord blood bank programs which have adopted the BioArchive System as their standard. The MDA Central Blood Bank is planning for an October 2001 opening of the cord blood stem cell banking facility.
This will be the first BioArchive System to be installed in Israel. Placement of the BioArchive System at this premier stem cell bank in Israel moves the Company one country closer to its goal of establishing a global network of national cord blood bank programs which have adopted the BioArchive System as their standard. The MDA Central Blood Bank is planning for an October 2001 opening of the cord blood stem cell banking facility.